Invesaro

Stocks Health care SHPH

NASDAQ · Health care

Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

It posted a net loss of $10.3M. At June 30, 2026 it held $90.2K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 24, 2026.

Price
$4.01
+0.69% on the day · September 25, 2026
52-week range $2.58 to $55.90
Market cap
$4.1M

What Shuttle Pharmaceuticals Holdings, Inc. does

Shuttle Pharmaceuticals Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SHPH.

Revenue and profit by year

Net income
FY22: -$1.2M -$1.2M FY22FY22: -$5M -$5M FY22FY23: -$6.6M -$6.6M FY23FY24: -$9.1M -$9.1M FY24FY25: -$11.7M -$11.7M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$11.9M-$11.7M-$7.16n/a
2024n/a-$7.7M-$9.1M-$82.60n/a
2023n/a-$5.9M-$6.6M-$88.36-$5.6M
2022n/a-$2.3M-$5M-$126.15n/a
2022n/a-$1.7M-$1.2M-$52.20n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around February 3, 2027.

Estimated from its filing rhythm: about 132 days after its last report of September 24, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What Shuttle Pharmaceuticals Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 24, 2026
    Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$3.10 versus -$32.91.
  2. September 24, 2026
  3. September 16, 2026
  4. September 11, 2026
  5. September 2, 2026
  6. September 2, 2026
  7. September 1, 2026
  8. August 28, 2026
  9. August 17, 2026
  10. August 17, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 15, 2026. Insider transactions on SEC

Insider trades

What the people running Shuttle Pharmaceuticals Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $181.8K and sold $504.8K worth of shares in the last 90 days.

Bought (open market)
$181.8K
last 90 days
Sold
$504.8K
last 90 days
Net sold
67,884
$323.1K
DateInsiderWhatSharesPriceValueFiling
July 14, 2026 Hrt Financial LP10% owner Sold 82,116 $4.48 $367.9K Form 4
July 13, 2026 Hrt Financial LP10% owner Sold 1,033 $4.67 $4.8K Form 4
July 10, 2026 Hrt Financial LP10% owner Bought 731 $3.11 $2.3K Form 4
July 9, 2026 Hrt Financial LP10% owner Bought 8,266 $3.38 $27.9K Form 4
July 8, 2026 Hrt Financial LP10% owner Sold 18,531 $3.52 $65.2K Form 4
July 7, 2026 Hrt Financial LP10% owner Sold 10,580 $3.33 $35.2K Form 4
July 6, 2026 Hrt Financial LP10% owner Sold 9,022 $3.51 $31.7K Form 4
July 2, 2026 Hrt Financial LP10% owner Bought 7,851 $3.54 $27.8K Form 4
July 1, 2026 Hrt Financial LP10% owner Bought 3,959 $3.30 $13.1K Form 4
June 30, 2026 Hrt Financial LP10% owner Bought 6,755 $3.23 $21.8K Form 4
June 29, 2026 Hrt Financial LP10% owner Bought 25,836 $3.44 $88.9K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about SHPH

What does Shuttle Pharmaceuticals Holdings, Inc. do?

Shuttle Pharmaceuticals Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SHPH.

Is Shuttle Pharmaceuticals Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $10.3M.

When did Shuttle Pharmaceuticals Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on September 24, 2026. It covers the period to June 30, 2026.

Similar companies

Compare SHPH with

Compare SHPH with any company

Follow SHPH

Get an email when Shuttle Pharmaceuticals Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SHPH: get an email when it files

Where the numbers come from

Financial figures are the values Shuttle Pharmaceuticals Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.